Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 2
2002 2
2003 3
2004 3
2005 3
2006 2
2018 2
2019 3
2020 1
2021 2
2022 5
2023 1
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Endocrine disruptors in obesity.
Asteria C, Morpurgo PS, Cerutti N, Hall JM. Asteria C, et al. Among authors: morpurgo ps. Front Endocrinol (Lausanne). 2024 Dec 24;15:1526898. doi: 10.3389/fendo.2024.1526898. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39777223 Free PMC article. No abstract available.
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide.
Lunati ME, Cimino V, Bernasconi D, Gandolfi A, Morpurgo PS, Tinari C, Lazzaroni E, Baruffaldi L, Muratori M, Montefusco L, Pastore I, Rossi A, Franzetti IG, Muratori F, Manfrini R, Disoteo OE, Terranova R, Desenzani P, Girelli A, Ghelardi R, D'Addio F, Ben Nasr M, Berra C, Folli F, Bucciarelli L, Fiorina P. Lunati ME, et al. Among authors: morpurgo ps. Pharmacol Res. 2024 Jan;199:107040. doi: 10.1016/j.phrs.2023.107040. Epub 2023 Dec 20. Pharmacol Res. 2024. PMID: 38128857 Free article.
SGLT2-inhibitors are effective and safe in the elderly: The SOLD study.
Lunati ME, Cimino V, Gandolfi A, Trevisan M, Montefusco L, Pastore I, Pace C, Betella N, Favacchio G, Bulgheroni M, Bucciarelli L, Massari G, Mascardi C, Girelli A, Morpurgo PS, Folli F, Luzi L, Mirani M, Pintaudi B, Bertuzzi F, Berra C, Fiorina P. Lunati ME, et al. Among authors: morpurgo ps. Pharmacol Res. 2022 Sep;183:106396. doi: 10.1016/j.phrs.2022.106396. Epub 2022 Aug 12. Pharmacol Res. 2022. PMID: 35970329
Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study.
Lazzaroni E, Lunati ME, Montefusco L, Pastore I, Chebat E, Cimino V, Morpurgo PS, Muratori M, Plebani L, Bolla A, Rossi A, Vallone L, Gandolfi A, Tinari C, D'Addio F, Nasr MB, Loretelli C, Scaranna C, Bellante R, Manfrini R, Muratori F, Franzetti I, Orsi E, Gazzaruso C, Ghelardi R, Desenzani P, Genovese S, Girelli A, Folli F, Berra C, Fiorina P. Lazzaroni E, et al. Among authors: morpurgo ps. Pharmacol Res. 2022 Sep;183:106374. doi: 10.1016/j.phrs.2022.106374. Epub 2022 Jul 28. Pharmacol Res. 2022. PMID: 35908663
Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes.
D'Addio F, Sabiu G, Usuelli V, Assi E, Abdelsalam A, Maestroni A, Seelam AJ, Ben Nasr M, Loretelli C, Mileto D, Rossi G, Pastore I, Montefusco L, Morpurgo PS, Plebani L, Rossi A, Chebat E, Bolla AM, Lunati ME, Mameli C, Macedoni M, Antinori S, Rusconi S, Gallieni M, Berra C, Folli F, Galli M, Gismondo MR, Zuccotti G, Fiorina P. D'Addio F, et al. Among authors: morpurgo ps. Diabetes. 2022 Aug 1;71(8):1800-1806. doi: 10.2337/db22-0053. Diabetes. 2022. PMID: 35551366 Free article.
Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathy.
D'Addio F, Pastore I, Loretelli C, Valderrama-Vasquez A, Usuelli V, Assi E, Mameli C, Macedoni M, Maestroni A, Rossi A, Lunati ME, Morpurgo PS, Gandolfi A, Montefusco L, Bolla AM, Ben Nasr M, Di Maggio S, Melzi L, Staurenghi G, Secchi A, Bianchi Marzoli S, Zuccotti G, Fiorina P. D'Addio F, et al. Among authors: morpurgo ps. Acta Diabetol. 2022 Sep;59(9):1157-1167. doi: 10.1007/s00592-022-01911-1. Epub 2022 Jun 22. Acta Diabetol. 2022. PMID: 35729357 Free PMC article.
Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS, Cappiello V, Verga U, Vicentini L, Vaghi I, Lauri E, Nebuloni M, Beck-Peccoz P, Spada A. Morpurgo PS, et al. Clin Endocrinol (Oxf). 2005 Oct;63(4):437-41. doi: 10.1111/j.1365-2265.2005.02360.x. Clin Endocrinol (Oxf). 2005. PMID: 16181236
Vaccinome Landscape in Nearly 620 000 Patients With Diabetes.
D'Addio F, Lazzaroni E, Lunati ME, Preziosi G, Ercolanoni M, Turola G, Marrocu C, Cicconi G, Sharma S, Scarioni S, Montefusco L, Pastore I, Morpurgo PS, Rossi A, Gandolfi A, Tinari C, Rossi G, Ben Nasr M, Loretelli C, Fiorina RM, Grassa B, Terranova R, Bucciarelli L, Berra C, Cereda D, Zuccotti G, Borriello CR, Fiorina P. D'Addio F, et al. Among authors: morpurgo ps. J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1590-e1597. doi: 10.1210/clinem/dgae476. J Clin Endocrinol Metab. 2025. PMID: 39040010 Free PMC article.
Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort Study.
Lunati ME, Morpurgo PS, Rossi A, Gandolfi A, Cogliati I, Bolla AM, Plebani L, Vallone L, Montefusco L, Pastore I, Cimino V, Argenti S, Volpi G, Zuccotti GV, Fiorina P. Lunati ME, et al. Among authors: morpurgo ps. Front Endocrinol (Lausanne). 2022 Apr 14;13:816599. doi: 10.3389/fendo.2022.816599. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35498423 Free PMC article.
32 results